Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist competition: GlobalData Read more
Viking Therapeutics’ obesity drug could become direct competitor to Eli Lilly’s tirzepatide: GlobalData Read more
Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData Read more